Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis

A patient with HER2-positive early breast cancer (BC) developed dermatomyositis (DM), which disappeared after the first administration of adjuvant trastuzumab. No HER2 overexpression/amplification was observed in DM skin biopsies. Both BC and skin immune infiltrates were composed mostly of CD3+ T-ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrino, Benedetta, Mazzaschi, Giulia, Madeddu, Denise, Mori, Cristina, Lagrasta, Costanza Anna Maria, Missale, Gabriele, Quaini, Federico, Musolino, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052038/
https://www.ncbi.nlm.nih.gov/pubmed/32158689
http://dx.doi.org/10.3389/fonc.2020.00192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052038/
https://www.ncbi.nlm.nih.gov/pubmed/32158689
http://dx.doi.org/10.3389/fonc.2020.00192

Ejemplares similares